RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas

Christopher S. Gondi, Sajani S. Lakka, Dzung H. Dinh, William C. Olivero, Meena Gujrati, Jasti S. Rao

Research output: Contribution to journalArticle

Abstract

RNA interference (RNAi) provides a powerful method for gene silencing in eukaryotic cells, including proliferating mammalian cells. Here, we determined whether RNAi could be utilized to inhibit the expression of proteases implicated in the extracellular matrix degradation, which is characteristic of tumor progression. We have previously shown that antisense stable clones of uPAR and cathepsin B were less invasive and did not form tumors when injected intracranially ex vivo. Since antisense-mediated gene silencing does not completely inhibit the translation of target mRNA and high molar concentrations of antisense molecules are required to achieve gene silencing, we used the RNAi approach to silence uPAR and cathepsin B in this study. We found that the expression of double-stranded RNA leads to the efficient and specific inhibition of endogenous uPAR and cathepsin B protein expression in glioma cell lines as determined by Western blotting. We also found the RNAi of uPAR and cathepsin B reduces glioma cell invasion and angiogenesis in in vitro and in vivo models. Intratumoral injections of plasmid vectors expressing hpRNA for uPAR and cathepsin B resulted in the regression of pre-established intracranial tumors. Further, RNAi for uPAR and cathepsin B inhibited cell proliferation and reduced the levels of pERK and pFAK compared to controls. Taken together, our findings indicate for the first time that RNAi operates in human glioma cells with potential application for cancer gene therapy.

Original languageEnglish (US)
Pages (from-to)8486-8496
Number of pages11
JournalOncogene
Volume23
Issue number52
DOIs
StatePublished - Nov 4 2004

Fingerprint

Cathepsin B
RNA Interference
Glioma
Gene Silencing
Growth
Neoplasms
Double-Stranded RNA
Neoplasm Genes
Protein Biosynthesis
Eukaryotic Cells
Genetic Therapy
Extracellular Matrix
Plasmids
Peptide Hydrolases
Clone Cells
Western Blotting
Cell Proliferation
Cell Line
Injections
Proteins

Keywords

  • Angiogenesis
  • Cathepsin and uPAR
  • Gliomas
  • Invasion
  • RNA interference

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Gondi, C. S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2004). RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene, 23(52), 8486-8496. https://doi.org/10.1038/sj.onc.1207879

RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. / Gondi, Christopher S.; Lakka, Sajani S.; Dinh, Dzung H.; Olivero, William C.; Gujrati, Meena; Rao, Jasti S.

In: Oncogene, Vol. 23, No. 52, 04.11.2004, p. 8486-8496.

Research output: Contribution to journalArticle

Gondi, Christopher S. ; Lakka, Sajani S. ; Dinh, Dzung H. ; Olivero, William C. ; Gujrati, Meena ; Rao, Jasti S. / RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. In: Oncogene. 2004 ; Vol. 23, No. 52. pp. 8486-8496.
@article{b94c6f18d62c4697a4d96512dbe2f6ab,
title = "RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas",
abstract = "RNA interference (RNAi) provides a powerful method for gene silencing in eukaryotic cells, including proliferating mammalian cells. Here, we determined whether RNAi could be utilized to inhibit the expression of proteases implicated in the extracellular matrix degradation, which is characteristic of tumor progression. We have previously shown that antisense stable clones of uPAR and cathepsin B were less invasive and did not form tumors when injected intracranially ex vivo. Since antisense-mediated gene silencing does not completely inhibit the translation of target mRNA and high molar concentrations of antisense molecules are required to achieve gene silencing, we used the RNAi approach to silence uPAR and cathepsin B in this study. We found that the expression of double-stranded RNA leads to the efficient and specific inhibition of endogenous uPAR and cathepsin B protein expression in glioma cell lines as determined by Western blotting. We also found the RNAi of uPAR and cathepsin B reduces glioma cell invasion and angiogenesis in in vitro and in vivo models. Intratumoral injections of plasmid vectors expressing hpRNA for uPAR and cathepsin B resulted in the regression of pre-established intracranial tumors. Further, RNAi for uPAR and cathepsin B inhibited cell proliferation and reduced the levels of pERK and pFAK compared to controls. Taken together, our findings indicate for the first time that RNAi operates in human glioma cells with potential application for cancer gene therapy.",
keywords = "Angiogenesis, Cathepsin and uPAR, Gliomas, Invasion, RNA interference",
author = "Gondi, {Christopher S.} and Lakka, {Sajani S.} and Dinh, {Dzung H.} and Olivero, {William C.} and Meena Gujrati and Rao, {Jasti S.}",
year = "2004",
month = "11",
day = "4",
doi = "10.1038/sj.onc.1207879",
language = "English (US)",
volume = "23",
pages = "8486--8496",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "52",

}

TY - JOUR

T1 - RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas

AU - Gondi, Christopher S.

AU - Lakka, Sajani S.

AU - Dinh, Dzung H.

AU - Olivero, William C.

AU - Gujrati, Meena

AU - Rao, Jasti S.

PY - 2004/11/4

Y1 - 2004/11/4

N2 - RNA interference (RNAi) provides a powerful method for gene silencing in eukaryotic cells, including proliferating mammalian cells. Here, we determined whether RNAi could be utilized to inhibit the expression of proteases implicated in the extracellular matrix degradation, which is characteristic of tumor progression. We have previously shown that antisense stable clones of uPAR and cathepsin B were less invasive and did not form tumors when injected intracranially ex vivo. Since antisense-mediated gene silencing does not completely inhibit the translation of target mRNA and high molar concentrations of antisense molecules are required to achieve gene silencing, we used the RNAi approach to silence uPAR and cathepsin B in this study. We found that the expression of double-stranded RNA leads to the efficient and specific inhibition of endogenous uPAR and cathepsin B protein expression in glioma cell lines as determined by Western blotting. We also found the RNAi of uPAR and cathepsin B reduces glioma cell invasion and angiogenesis in in vitro and in vivo models. Intratumoral injections of plasmid vectors expressing hpRNA for uPAR and cathepsin B resulted in the regression of pre-established intracranial tumors. Further, RNAi for uPAR and cathepsin B inhibited cell proliferation and reduced the levels of pERK and pFAK compared to controls. Taken together, our findings indicate for the first time that RNAi operates in human glioma cells with potential application for cancer gene therapy.

AB - RNA interference (RNAi) provides a powerful method for gene silencing in eukaryotic cells, including proliferating mammalian cells. Here, we determined whether RNAi could be utilized to inhibit the expression of proteases implicated in the extracellular matrix degradation, which is characteristic of tumor progression. We have previously shown that antisense stable clones of uPAR and cathepsin B were less invasive and did not form tumors when injected intracranially ex vivo. Since antisense-mediated gene silencing does not completely inhibit the translation of target mRNA and high molar concentrations of antisense molecules are required to achieve gene silencing, we used the RNAi approach to silence uPAR and cathepsin B in this study. We found that the expression of double-stranded RNA leads to the efficient and specific inhibition of endogenous uPAR and cathepsin B protein expression in glioma cell lines as determined by Western blotting. We also found the RNAi of uPAR and cathepsin B reduces glioma cell invasion and angiogenesis in in vitro and in vivo models. Intratumoral injections of plasmid vectors expressing hpRNA for uPAR and cathepsin B resulted in the regression of pre-established intracranial tumors. Further, RNAi for uPAR and cathepsin B inhibited cell proliferation and reduced the levels of pERK and pFAK compared to controls. Taken together, our findings indicate for the first time that RNAi operates in human glioma cells with potential application for cancer gene therapy.

KW - Angiogenesis

KW - Cathepsin and uPAR

KW - Gliomas

KW - Invasion

KW - RNA interference

UR - http://www.scopus.com/inward/record.url?scp=9144231998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144231998&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1207879

DO - 10.1038/sj.onc.1207879

M3 - Article

VL - 23

SP - 8486

EP - 8496

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 52

ER -